Skip to main content

Find Clinical Trials

Home
Conditions
Relapsed or Refractory Plasma Cell Neoplasms

Clinical trial condition

Relapsed or Refractory Plasma Cell Neoplasms

Explore clinical trials studying Relapsed or Refractory Plasma Cell Neoplasms. Study availability and eligibility vary by location and protocol.

3 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Relapsed or Refractory Plasma Cell Neoplasms trial results

Recruiting

CAR 70-BCMA CAR-T Cells for the Treatment of Relapsed or Refractory Plasma Cell Neoplasms

NCT07519187

Conditions: Disease Attributes, Neoplasms, Neoplasms by Histologic Type, +5 more
Locations: General Hospital of Western Theater Command of PLA Chengdu, China

View Trial Details

Not Yet Recruiting

CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms and Lymphomas/Leukemias With Plasmacytic Differentiation

NCT06986434

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: the Fifth Medical Center of Chinese People's Liberation Army General Hospital Beijing, China

View Trial Details

Not Yet Recruiting

CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms

NCT07077330

Conditions: Disease Attributes, Neoplasms, Neoplasms by Histologic Type, +5 more
Locations: The Four Medical Center of PLA General Hospital, China Beijing, China

The Six Medical Center of PLA General Hospital, China Beijing, China

View Trial Details